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Imported Mollusks 
and Dissemination 
of Human Enteric 
Viruses 
To the Editor: The globaliza-
tion of food production and trade has 
increased the potential risk for infec-
tious foodborne diseases. Hepatitis 
A virus (HAV) and norovirus (NoV) 
constitute the most important food-
borne pathogens of humans in terms 
of numbers of outbreaks and persons 
affected in industrialized countries 
(1,2). In these countries, improvement 
of health conditions and development 
of specifi c vaccines are changing the 
epidemiologic pattern of diseases such 
as hepatitis A, decreasing their preva-
lence and increasing the susceptibility 
of the unvaccinated adult population 
(1). In recent years, numerous cases 
of gastroenteritis caused by NoV and 
hepatitis A linked to imported shellfi sh 
have been reported (2–5). In Spain, 2 
notable hepatitis A outbreaks associ-
ated with clams (Donax sp.) imported 
from Peru occurred in 1999 and 2008. 
In both situations, the Spanish Min-
istry of Health activated the National 
System of Epidemiologic Surveil-
lance and the European Community 
Rapid Alert System for Foodstuffs. 
The implicated shellfi sh batches were 
immobilized or removed, and all the 
shellfi sh from Peru were banned from 
the European Union (6). We present 
further evidence that imported shell-
fi sh from developing countries, where 
these pathogens are endemic, can be 
a vehicle for viral gastroenteritis and 
HAV infections in areas where they 
are not endemic.
Fifty mollusk samples imported 
into Spain during September 2006–
March 2009 were analyzed for NoV 
genotype I (GI) and GII, HAV and 
astrovirus (AsV). Countries of ori-
gin were Morocco, Peru, Vietnam, 
and South Korea (Table). The species 
studied were clams (Callista chione, 
n = 25; Transanella pannosa, n = 6; 
Meretrix lyrata, n = 3; and Donax sp., 
n = 5), oysters (Crassostrea angulata, 
n = 1), cockles (Cerastoderma edule, 
n = 1), and razor clams (Solen mar-
ginatus, n = 1 and Ensis sp., n = 8). 
Digestive tissue was dissected from 
duplicated samples (10–20 individual 
mollusks) and homogenized with 0.1% 
peptone water (pH 7.4), centrifuged at 
1,000 × g for 5 min, and supernatant 
recovered. RNA was extracted by us-
ing both Total Quick RNA extraction 
Cells and Tissue kit (Talent, Trieste, 
Italy) and Nucleospin RNA Virus Kit 
(Macherey-Nagel, Düren, Germany).
NoV and HAV were detected by 
real-time reverse transcription–PCR 
(RT-PCR) by using the Platinum 
Quantitative RT-PCR Thermoscript 
1-step system (Invitrogen, Carlsbad, 
CA, USA) (25 μL fi nal volume) with 
5 μL of template RNA, and primers, 
probes, and conditions as described 
(7). A sample that displayed a cycle 
threshold value <41 was considered 
positive. AsV was detected by stan-
dard RT-PCR (7), coupled with hy-
bridization by using specifi c biotin-
labeled probes with the commercial 
Kit Hybridowell universal (Argene, 
Varilhes, France).
Negative and specifi c positive 
controls for HAV, NoV, and AsV were 
introduced in each run. Real-time RT-
PCR included appropriate external 
controls in each analysis to avoid un-
derestimation of viral load. A mutant, 
nonvirulent, infective strain of men-
govirus (vMC0) (10
3 PFU) was used 
as control for extraction. To calculate 
the real-time RT-PCR effi ciencies, ex-
ternal viral RNA (HAV, 103 copies) 
or synthetic DNA (NoV, 105 copies) 
controls for the respective virus were 
co-amplifi ed with each template viral 
RNA as described (8). The number of 
RNA viral genome copies per gram of 
digestive tissue (RNA copies/g diges-
tive tissue) was estimated by using 
standard curves generated from RNA 
transcripts and synthetic DNA (8) and 
corrected with the extraction and real-
time RT-PCR effi ciencies.
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Twenty (40%) of 50 samples were 
contaminated by >1 virus (Table), al-
though all the mollusk imports com-
plied with the current sanitary stan-
dards. NoV GI was most prevalent, 
detected in 24% of samples, followed 
by AsV (18%), NoV GII (8%), and 
HAV (4%). One sample showed a low 
extraction effi ciency (<1%), yielding 
all samples high real-time RT-PCR ef-
fi ciencies (>10%) (9).
Six samples (30% of positive 
samples) were positive for >1 vi-
rus. Thus, 2 samples from Morocco 
showed contamination with NoV GI 
and AsV. From Peru, 1 sample was 
contaminated with both genogroups 
of NoV and another with NoV GI, 
NoV GII, and AsV. Samples from 
Vietnam (n = 2) were contaminated 
with HAV–NoV GI and NoV GI–
AsV. Co-infection with different vi-
ruses or multiple virus strains could 
lead to more severe symptoms and 
the occurence of 2 episodes of the 
same or different diseases and also be 
a way to facilitate emergence of new 
recombinant strains (10). 
Contamination levels for NoV 
GI ranged from 3.5 × 104 to 7.7 × 107 
RNA copies/g digestive tissue; for 
NoV GII, from 1.03 × 105 to 8.9 ×105 
RNA copies/g digestive tissue; and 
for HAV, from 4.7 × 103 to 4.4 × 107 
RNA copies/g digestive tissue (Table). 
For HAV, these values are in the same 
range or even higher than in the co-
quina clams from Peru implicated in 
the outbreak in Spain in 2008, which 
is noteworthy because the attack rate 
for different batches of shellfi sh is 
dose dependent (6).
Determining the association of a 
viral infection with a particular con-
taminated product is often compli-
cated, and the epidemiologic inves-
tigations necessary for fi nding this 
association are time consuming and 
allow the virus to spread before the 
problem is recognized. Furthermore, 
there are analytical diffi culties in de-
tecting and quantifying virus in shell-
fi sh samples and in monitoring them; 
other problems include ascertaining 
the representativeness of the sample 
(2,6) and the high cost of applying the 
technique in areas with extensive mol-
lusk production.
The inadequacy of the bacte-
rial indicators makes it necessary to 
develop new prevention strategies, 
based on microbial risk assessment, 
to ensure the sanitary quality of shell-
fi sh, both in production areas and in 
international trade operations. Imple-
menting these methods and providing 
training to laboratories in developing 
countries are essential to achieving 
these objectives.
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Table. Viral detection and quantification in imported mollusk samples* 
Country of origin 
(no. samples) 
HAV positive† 
Norovirus positive 
Astrovirus
positive, no. (%)¶
GI‡ GII§ 
No. (%) QR No. (%) QR No. (%) QR 
Morocco (34) 5 (15) 3.5 x 104–1.1 x 107 2 (6) 1.4 x 105–8.9 x 105 7 (21) 
Peru (13) 1 (8) 4.7 x 103 4 (31) 2 x 105–1.8 x 107 2 (15) 1 x 105–1.4 × 106 1 (8) 
Vietnam (2) 1 (50) 4.4 x 107 2 (100) 3.3 x 106–7.7 x 107 1 (50) 
South Korea (1) 1 (100) 1.2 × 106 –
Total (50) 2 (4) 103–107 12 (24) 104–107 4 (8) 105–106 9 (18) 
*HAV, hepatitis A virus; GI, genotype I; QR, quantification range (RNA copies/g digestive tissue). 
†Obtained from Donax sp. and Meretrix lyrata. 
‡Obtained from Donax sp., Callista chione, Transanella pannosa, M. lyrata, and Ensis sp. 
§Obtained from Donax sp., T. pannosa, and Ensis sp. 
¶Obtained from C. chione, T. pannosa, M. lyrata, and Ensis sp. 
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Atypical 
Chikungunya Virus 
Infections in 
Immuno-
compromised 
Patients 
To the Editor: Chikungunya fe-
ver was fi rst described in Tanganyika 
(now Tanzania) in 1952 and is now 
emerging in Southeast Asia. Chi-
kungunya virus (CHIKV) infection, 
a self-limiting febrile illness, shares 
similarities with dengue fever such 
as headache and myalgia. Addition-
ally, patients with CHIKV infection 
typically have arthralgia, arthritis, 
and tenosynovitis (1). Although usu-
ally benign, CHIKV infection may 
on rare occasions lead to neurologic 
and hepatic manifestations with high 
illness and mortality rates (2). We re-
port 2 immunocompromised patients 
with CHIKV infection associated with 
peritonitis, encephalitis, and second-
ary bacterial infections.
Patient A, a 66-year-old Singa-
porean-Chinese man, had a history 
of chronic renal disease secondary 
to obstructive uropathy. His baseline 
creatinine level was 300–400 μmol/L. 
For 3 years, he had ingested tradi-
tional Chinese medicine, which we 
suspect was contaminated by steroids 
because he appeared cushingoid. An 
outbreak of CHIKV infection was 
reported at his workplace. He was 
admitted to National University Hos-
pital, Singapore, in July 2008 with 
abdominal pain, vomiting, and fever 
of 1 day. He had no joint symptoms. 
Clinically, he had systemic infl amma-
tory response syndrome complicated 
by acute-on-chronic renal failure. His 
creatinine level was elevated at 921 
μmol/L on admission. A complete 
blood count showed leukocytosis 
(19.24 × 109 cells/L) with neutro-
philia and thrombocytopenia (62 × 
109 cells/L). Initial blood and urine 
cultures and serologic results were 
negative for dengue virus, but serum 
reverse transcription–PCR (RT-PCR) 
and indirect immunofl uorescent as-
say for immunoglobulin G (IgG) 
(Euroimmun Medizinische Labor-
diagnostika, Lubeck, Germany) and 
IgM (CTK Biotech, Inc, San Diego, 
CA, USA) were positive for CHIKV 
(3,4). Computed tomographic scans 
of the abdomen showed dilated small 
bowel loops.
An urgent laparotomy did not 
show bowel perforation, but peritone-
al cultures yielded Klebsiella pneumo-
niae, Escherichia coli, and Candida 
glabrata, and RT-PCR from the con-
centrated peritoneal fl uid was positive 
for CHIKV (3). He was administered 
appropriate antimicrobial drugs. He 
required repeat laparotomies because 
of elevated intraabdominal pres-
sure. He subsequently received broad 
spectrum antimicrobial drugs to treat 
secondary intraabdominal infections 
caused by P. aeruginosa and Entero-
coccus faecalis.
Ventilator-associated pneumonia 
also developed. Despite maximal sup-
port and prolonged antimicrobial ther-
apy, this patient died after 5 months of 
hospitalization.
Patient B, a 45-year-old Ma-
laysian–Chinese man with diabetes 
mellitus, had undergone a cadaveric 
liver transplant in 2001 for hepatitis 
B liver cirrhosis. He was receiving 
immunosuppressants (azathioprine 
and prednisolone). He was admitted 
in August 2008 after experiencing fe-
ver, headache, and abdominal bloat-
ing for 3 days. He had no neurologic 
symptoms. Acute self-limiting febrile 
illnesses with arthritis had occurred 
in his hometown; CHIKV infections 
were suspected.
Results of his examination on 
admission were normal, except for bi-
lateral enlarged cervical lymph nodes. 
Chest radiograph results were unre-
markable. He had mild transaminitis 
(alanine aminotransferase 173 U/L, 
aspartate aminotransferase 170 U/L), 
elevated C-reactive protein (107 
mg/L), and thrombocytopenia (120 
× 109 cells/L) without leukocytosis. 
Results of comprehensive serum and 
urine microbial studies were negative 
for posttransplant infections. Results 
of serum RT-PCR were negative for 
CHIKV, but IgG and IgM tests were 
positive for CHIKV.
Brain magnetic resonance im-
aging was performed because of the 
patient’s persistent severe headache 
and transient drowsiness. It showed 
several nonspecifi c areas of enhance-
ment, which suggested encephalitis, 
given the clinical scenario (Figure). 
However, a lumbar puncture was not 
performed, and hence, whether the 
patient’s cerebrospinal fl uid contained 
CHIKV could not be determined. 
Bilateral frontoparietal white mat-
ter lesions with restricted diffusion 
has been suggested as an early sign 
of viral encephalitis (5). However, a 
retrospective series demonstrated that, 
in CHIKV encephalitis, abnormalities 
on magnetic resonance imaging were 
uncommon, and no pathognomonic 
features were found (6).
Hospital-acquired pneumonia also 
developed and was treated with broad-
spectrum antimicrobial drugs. Bron-
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